Brind.

GRAIL reported an impairment of assets related to its acquisition of Illumina.

2 reports, 2 independent Updated Sep 17

Gone quiet

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

GRAIL reported an impairment of assets related to its acquisition of Illumina.

Who's involved

What this event is mainly about

GRAIL Illumina

Keep exploring

The entities involved

GRAIL
American biotechnology and pharmaceutical company
- A lawsuit was filed against GRAIL in the Northern District of California.Mon 01:43
- A lawsuit was filed in New York City involving the company GRAIL.Sun 23:51
Illumina
American company that develops systems for the analysis of genetic variation

Nothing else this week.

Coverage

Newest first; wire copies grouped

Sep 17cnbc.com
Aug 13PR NewswireGRAIL Reports Second Quarter 2025 Financial Results Q2 U.S. Galleri Revenue Grew 21% Year-Over-Year to $34.2 Million Q2 Galleri Tests Sold Grew 29% Year-Over-Year to More Than 45,000 Detailed Results